Acne Vulgaris Treatment Market Competitive Analysis, Regional Outlook and Forecast Analysis during 2022-2028

 

Acne Vulgaris Treatment Market

Blackheads, whiteheads, papules, and pustules on the face, neck, back, and chest are the main features of the common skin condition acne vulgaris. Although frequently seen in adolescents, it can also affect adults. Acne can be divided into three categories: mild, moderate, and severe. Sebaceous glands under the skin produce too much oil, which causes them to clog and swell. Acne can also affect female patients with polycystic ovarian syndrome and even hormonal issues like excessive androgen production. Social withdrawal, low self-esteem, and depression with suicidal thoughts are common in people with acne vulgaris.

Over the forecast period, the U.S. is anticipated to be the Global Acne Vulgaris Treatment Market with the highest volume of acne vulgaris treatment products. A 2015 study that was published in the British Journal of Dermatology estimated that 9.4% of the world's population suffered from acne. Additionally, acne is the eighth most common disease in the world. The biggest market for treatments for acne vulgaris is the United States. Over $3 billion was spent on treating acne vulgaris in the United States in 2013, according to a study by the National Institutes of Health (NIH). According to the American Academy of Dermatology, the number of acne vulgaris patients aged 25 and older, particularly women, is significantly increasing in 2014. Furthermore, low awareness regarding the factors causing acne is another factor leading to increasing prevalence acne vulgaris.

Acne Vulgaris Treatment Market Product types-

·        Medications

o   Benzoyl peroxides

o   Retinoids

o   Systemic and topical Antibiotics

o   Hormonal Agents

o   Others (Salicylic Acid, Azelic, Dapsone, and Alternative therapy)

·        Devices

·        Laser devices

·        Heat extraction devices

By 2020, India is anticipated to have the largest population in the 15–25 year age group. As a result, the market for acne vulgaris treatment products is extremely lucrative. Additionally, India has a high glycemic index diet, which is anticipated to help the market grow over the course of the forecast period. Manufacturers are also concentrating on creating products to treat acne-related scarring. Scarring is being treated with new surgical and cosmetic methods, such as laser, chemical peels, and photodynamic therapy. Another factor anticipated to support the growth of the acne vulgaris treatment market is rising consumer preference for alternative methods of treating acne vulgaris, such as herbal therapy (tee tree oil), due to their lack of side effects.

Over the forecast period, home-based acne treatment equipment like Neutrogena and Revive light therapy will see significant growth. In order to improve their product offerings and maintain their market share, major players in the acne vulgaris treatment market are concentrating on partnering, acquiring, and developing new products. For instance, the global beauty company L'Oréal signed a contract with Valeant Pharmaceuticals International, Inc. in 2017 to purchase its portfolio of skin care brands, which included the anti-acne brand AcneFree, for US$1.3 billion. Additionally, Novan Inc. announced in November 2017 that it would carry out a phase three clinical trial for a new anti-acne molecule.

Nitrici, a proprietary nitric oxide technology from Novan, enables the controlled release of nitric oxide from chemical entities. This is advantageous because nitric oxide naturally has the power to regenerate tissue, eliminate invasive microorganisms, prevent clotting, control inflammation, and even help eliminate cancer cells. A further agreement to sell its Obagi Medical Products business for US$ 190 million in cash was signed by Valeant Pharmaceuticals International, Inc. and Haitong International Zhonghua Finance Acquisition Fund I, L.P. in 2017. The market for acne treatment products has a significant presence of Obagi Medical Products.

Major Companies Listed are- Allergan plc, GlaxoSmithKline plc, Valeant Pharmaceutical International Inc., F.Hoffmann-La Roche AG, Mylan, N.V., Bayer AG, Janssen Pharma Inc., Galderma Inc., Pfizer Inc., and Novan Inc.

Comments

Post a Comment

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

Image
Security Robot Market The Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period of 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Security Robot Market encompasses advanced robotic technologies that are specifically designed and developed to enhance security and surveillance operations. These robots are equipped with features such as video surveillance, thermal imaging, facial recognition, and intrusion detection, among others. They are extensively used by security agencies and organizations across various sectors, including residential, commercial, industrial, and government, to enhance safety, reduce human intervention, and streamline security operations. Security robots offer real-time monitoring, remote control, and high accuracy, making them an ideal choice for surveillance in sensitive areas and remote locations. Market Dynamics:
Read more

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Image
  Scottish Whisky Market The Scottish Whisky Market is a captivating landscape that has been evolving and transforming over the years. It is a world of tradition, craftsmanship, and heritage, where every drop of whisky tells a story. The history of Scottish whisky traces back centuries, with the earliest records dating back to the 15th century. Whisky production initially started in monasteries, where monks distilled spirits for medicinal purposes. Over time, whisky production moved from monastic settings to farms and then to commercial distilleries. This transition marked the beginning of an industry that would become synonymous with Scotland. Scottish Whisky Market Was Valued At US$ 4.97 Bn In 2018, And It Is Expected To Reach US$ 7.89 Bn By The End Of 2027, Exhibiting A CAGR Of 5.3% During The Forecast Period (2019 To 2027). One of the defining characteristics of the Scottish Whisky Market is its adherence to traditional production methods. Scotch whisky is made from malted b
Read more

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides

Image
Monochloroacetic Acid (MCAA) Market The Monochloroacetic Acid (MCAA) Market is estimated to be valued at USD 676.52 Million in 2022 and is expected to exhibit a CAGR of 7.03% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Monochloroacetic Acid (MCAA) Market is driven by the increasing demand for surfactants and herbicides in several industries such as agriculture, pharmaceuticals, textiles, and personal care. MCAA is extensively used in the production of surfactants, herbicides, and carboxymethyl cellulose (CMC), which are essential in various applications. These applications include detergents, agrochemicals, pharmaceuticals, dyes, and cosmetics, among others. The versatile properties of MCAA, such as its ability to act as a raw material in the production of herbicides and surfactants, make it highly desirable in the market. Market Dynamics: The Monochloroacetic Acid (MCAA) Market is driven by two k
Read more